Showing 981 - 1,000 results of 63,942 for search '(( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 ((wt decrease) OR (we decrease)) ))', query time: 1.13s Refine Results
  1. 981
  2. 982

    Selective TASK‑1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability by Bárbara Arévalo (4053358)

    Published 2022
    “…Mutation of seven residues to A (I118A, L122A, F125A, Q126A, L232A, I235A, and L239A) markedly decreased the F3-induced inhibition of TASK-1 channels, consistent with the molecular modeling predictions. …”
  3. 983

    Selective TASK‑1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability by Bárbara Arévalo (4053358)

    Published 2022
    “…Mutation of seven residues to A (I118A, L122A, F125A, Q126A, L232A, I235A, and L239A) markedly decreased the F3-induced inhibition of TASK-1 channels, consistent with the molecular modeling predictions. …”
  4. 984

    BRET<sup>2</sup> measurement of Gα<sub>q</sub>β<sub>1</sub>γ<sub>2</sub> complex activation in HEK293 living cells expressing equal amounts of the WT of human TP receptor or its E1... by Valérie Capra (396007)

    Published 2013
    “…Total Gα<sub>q</sub>-Rluc8 luminescence was evaluated in HEK293 cells co-expressing Gα<sub>q</sub>-Rluc8 together with GFP<sup>10</sup>-Gγ<sub>2</sub> and Gβ<sub>1</sub> in the presence of WT or E129V mutant of the human TP receptor measuring the light emission in aliquots of the transfected cells incubated with 5 µM coelenterazine for 8 min. …”
  5. 985
  6. 986
  7. 987
  8. 988
  9. 989
  10. 990
  11. 991
  12. 992
  13. 993

    Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer by Ana Alfaro (280118)

    Published 2016
    “…Remarkably, this risk was higher for ACC (OR = 6.0, 95% CI = 1.1–33, p < 0.05) than for SCC (OR = 2.8, 95% CI = 1.3–5.9, p < 0.01). Interestingly, when analyzing only the HPV16-positive CC, D2 increases (OR = 2.5, 95% CI = 1.2–5, p < 0.05) and D3 decreases (OR = 0.45, 95% CI 0.2–0.9, p < 0.05) the risk to develop CC before 50 years old in relation with A1/2 variant. …”
  14. 994
  15. 995
  16. 996
  17. 997
  18. 998

    Neutralization of JRFL WT and mutant viruses by different MAbs and CD4-IgG2. by Chitra Upadhyay (817121)

    Published 2018
    “…A) Titration curves of representative virus-MAb pairs. B) JRFL WT and mutant neutralization by MAbs targeting V2i, V3, V2q, and the CD4bs and by CD-IgG2. …”
  19. 999
  20. 1000